Dupixent 300 MG/2 ML pen 2ML
Ended Awarded
- Contract number
- SPE2DB25FX53F
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $11,532
Award facts
- Contract value 100% obligated
- $11,531.64 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order valued at $11,531.64 to AmerisourceBergen Drug Corp for the supply of Dupixent (dupilumab) 300 mg/2 mL pen injectors on September 26, 2025. This non-competitive, firm fixed-price delivery order is set to be completed by September 29, 2025, with performance occurring at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal medical supply vendor, fulfills this order under its existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a $999.999 billion prime vehicle running through December 2026.
Dupixent is a biologic immunosuppressant used to treat moderate-to-severe atopic dermatitis, eosinophilic esophagitis, and asthma, making it a specialized pharmaceutical product supporting military and federal healthcare systems. This delivery order reflects the routine replenishment of critical specialty medications under the DLA's pharmaceutical supply chain operations, leveraging AmerisourceBergen's extensive federal contract portfolio and demonstrated capability to deliver brand-name and generic pharmaceuticals, vaccines, and medical supplies to support military healthcare programs globally. The award underscores the contractor's role as a preferred pharmaceutical vendor for the Defense Health Agency and other federal healthcare entities.
Quick answers
Who was awarded contract SPE2DB25FX53F?
SPE2DB25FX53F was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on September 26, 2025.
How much is contract SPE2DB25FX53F worth?
The government has obligated $11,532 on SPE2DB25FX53F.
Is contract SPE2DB25FX53F an order under another contract?
Yes. SPE2DB25FX53F is a delivery order under SPE2DB20D2200, an indefinite delivery contract.
Was contract SPE2DB25FX53F competed?
The extent of competition for SPE2DB25FX53F was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award